Choosing the right buffers and solvents is critical in LC-MS because the entire mobile phase directly enters the mass spectrometer. Compatibility with the ionization source (like ESI or APCI) is essential for high-quality data.

1. Why Volatile Buffers are Essential
Non-volatile salts, such as phosphate buffers, are unsuitable for LC-MS. As the mobile phase evaporates, these salts leave a residue that can:

Contaminate and clog the ion source.

Cause signal suppression.

Increase background noise.

Necessitate frequent and costly maintenance.

Volatile buffers are the solution. They provide stable pH control while being easily removed in the gas phase.

Benefits of Volatile Buffers:

High Sensitivity: They evaporate cleanly, allowing analytes to ionize efficiently without interference.

Low Background: Complete evaporation minimizes background ions, leading to a cleaner spectrum and better signal-to-noise.

System Stability: They prevent the residue buildup that plagues systems using non-volatile salts.

Common Volatile Buffers:

Ammonium Acetate (pH range ~4-6)

Ammonium Formate (pH range ~3-6)

Formic Acid / Acetic Acid (for acidic conditions)

Ammonium Hydroxide (for basic conditions)

2. Why Non-Polar Solvents Should Be Avoided
The choice of organic modifier is equally important. Non-polar solvents (like hexane or toluene) are not recommended for typical reversed-phase LC-MS for several reasons:

Poor Miscibility: Most LC-MS mobile phases are aqueous. Non-polar solvents are immiscible with water, which can cause phase separation.

Low Volatility & Unstable Spray: They do not evaporate efficiently in the MS source, leading to an unstable spray, a noisy baseline, and system contamination.

Ion Suppression: Their low dielectric constant is not conducive to good ion formation in ESI, resulting in poor signal intensity.

Safety Concerns: They often have higher toxicity and flammability.

3. Preferred Solvents for LC-MS
The most commonly used solvents are polar and volatile, such as Methanol and Acetonitrile.

These are ideal because they are:

Fully miscible with water.

Highly volatile, ensuring easy removal in the ion source.

Able to produce stable electrospray droplets, which promotes efficient ionization.

#PharmaceuticalAnalysis #MethodDevelopment #Principle #LCMS #UHPLC #HPLC #GC #GCMS #Volatile_Buffers #Non_polar_solvents #USP #IP #WHO #CDCSO #ICH #MHRA #AnalyticalChemistry #Solactivity #DrugDevelopment #Chemist #validation #science #pharma #GLP #SCIENCE #analytical #scientist #knowledge #sharing

Hello everyone im conducting HAA9 analysis in water samples with SPE in LC MS/MS and im observing reduced areas of the peaks over the months. The LC works normally for other methods. Can someone has the same problem in HAA analysis? Or doing the same analysis? The LCMS is the Shimadzu 8050. Thank you!

In UPLC during RP-HPLC Run with mobile phase as 0.1% TFA+ Water and 0.1%TFA+ ACN with 55 C column temp., the peak keeps shifting to wards left as the sequence continues.

What could be the reason.
Initially the for few runs the RT was consistent.

Any suggestions to look in to ?

Hello
I need full course on Hplc
I know the princble
I need help in how work & troubleshooting

Please Provide me the Tropicamide 1% Eye Drop HPLC related substance Method of analysis and impurities limit.

Best mobile phase for assay and their ratio mobile phase for better' resolution

How make integration on empower for hplc

Excited to announce a powerful new feature in HPLC Calculator app ?

? Fine-tuned on real HPLC problems and solutions
? Aligned with international analytical guidelines
? Helps identify issues, suggest fixes, and optimize methods

Whether you’re facing peak shape issues, retention problems, or compliance challenges, the AI Assistant is designed to provide practical, guideline-based answers.

Available now inside the app — making HPLC analysis smarter and easier than ever!
#HPLC_Calculator

Download it now

Appstore
https://apps.apple.com/eg/app/hplc-calculator/id1600330994


Play store

https://play.google.com/store/apps/details?id=com.Youhana.HPLC_Calculator

Now I try to analysis syrup contain Vit.D3 and calcium by hplc but i have difficulty separating to get clear result as assay
Can you give any method or tips

When developing an HPLC method, we often focus on column chemistry, mobile phase composition, and detection. But what happens when the compound itself is chiral?
Enantiomers — mirror-image molecules — behave identically in most achiral environments, which means they often co-elute as a single peak on standard C18 or C8 columns. In biological systems, however, their behavior can be dramatically different:
One enantiomer may provide the therapeutic effect.
The other may be inactive, or even harmful.
This is why regulatory agencies (ICH, FDA, EMA) require chiral separation and quantification during method development and validation. Enantiomeric purity is not only a regulatory requirement but also essential for patient safety and drug efficacy.
Strategies for Chiral Separation in HPLC:
Chiral Stationary Phases (CSPs) – polysaccharide, cyclodextrin, protein, or Pirkle-type columns that enable selective interactions.
Chiral Mobile Phase Additives (CMPAs) – such as cyclodextrins forming transient diastereomeric complexes.
Indirect Approach (Derivatization) – converting enantiomers into diastereomers with chiral reagents (e.g., Marfey’s, Mosher’s) for separation on achiral columns.
Key Considerations in Method Development:
Screening multiple CSPs to identify the best selectivity.
Selecting the appropriate elution mode (normal-phase, reversed-phase, polar organic).
Optimizing pH and temperature to improve resolution.
Ensuring scalability for both analytical and preparative applications.
In modern pharmaceutical analysis, chirality is more than just a separation challenge — it is a critical quality attribute that guarantees both drug safety and efficacy.
For professionals in analytical R&D and QC, developing strong expertise in chiral HPLC method development is essential. Chirality is not just chemistry; it is directly linked to patient safety.
#HPLC #Chirality #MethodDevelopment #AnalyticalChemistry #Pharma #DrugSafety #QualityControl

Impurities are unwanted chemicals that may be present in drug substances or finished products as a result of manufacturing, storage, or handling.

Types of Impurities
Process-related → unreacted starting materials, by-products, catalysts.
Degradation-related → formed through heat, oxidation, hydrolysis, or light.
Residual solvents → examples include methanol and dichloromethane.
Enantiomeric impurities → incorrect stereoisomers in chiral drugs.
According to ICH Q3A/Q3B, any impurity at or above 0.1% must be identified, with stricter thresholds for genotoxic impurities.

Identifying Impurities Using HPLC
Detection
The main API peak appears alongside smaller impurity peaks.
Characterization
Compare retention times with reference standards.
Use PDA detectors to check peak purity.
Confirm identity by co-injection with standards.
Structural Identification
LC-MS provides molecular weight and fragmentation patterns.
LC-NMR or LC-FTIR supplies structural fingerprints.
Together, these techniques give the complete chemical identity.

Examples of Well-Known Impurities

Nitrosamines (e.g., NDMA, NDEA)
Discovered in valsartan, ranitidine, and metformin between 2018–2019.
Classified as probable human carcinogens.
Regulatory limits are extremely low (nanogram levels).
Identified using HPLC-MS/MS.
p-Aminophenol (Paracetamol)
A toxic degradation product affecting liver and kidney.
Strictly limited to ≤0.1%.
Formaldehyde / Acetaldehyde
Residual solvent-related impurities found in excipients.
Detected using derivatization followed by HPLC.
Epimer impurities in chiral drugs
Wrong stereoisomers can be inactive or harmful.
The thalidomide case highlighted the risks.
Controlled and identified using chiral HPLC columns.

Why Impurity Profiling is Essential
Patient safety → prevents toxic exposure.
Regulatory compliance → required by ICH and FDA.
Process understanding → reveals weaknesses in synthesis or storage.
Shelf-life assurance → guarantees product safety until expiry.

Key Takeaway

Finding an extra peak in an HPLC chromatogram is only the first step. Comprehensive quality control requires:

Detection – observing the impurity peak.
Identification – determining chemical structure with advanced techniques.
Control – ensuring levels remain below regulatory limits.

Serial dilution is a fundamental laboratory technique used to reduce concentration step by step. It ensures accurate analysis of pharmaceutical compounds, supports method validation, and provides consistency across regulatory standards.

What is Serial Dilution?
Serial dilution involves repeatedly diluting a solution by a fixed factor (commonly 1:10 or 1:100) using a solvent. This creates a series of decreasing concentrations and is widely applied in:

Analytical method validation

Microbiological assays

Pharmaceutical quality control

Why is it Essential?

Precision: Enables preparation of reliable low-concentration standards for calibration and testing.

Consistency: Provides uniform preparation to support inter-laboratory reproducibility and compliance with regulatory requirements.

Versatility: Useful for preparing standards, quantifying active ingredients, and studying dose-response relationships.

Step-by-Step Guide

Prepare a stock solution by accurately weighing or measuring the compound and dissolving it in a suitable solvent.

Dilute sequentially by transferring a fixed volume of the stock into successive containers with solvent, mixing thoroughly at each step.

Document concentrations carefully to ensure traceability and accuracy.

Serial dilution is not just a routine laboratory practice—it is a strategic process that underpins precision, reliability, and the success of pharmaceutical research and regulatory compliance.

#PharmaceuticalScience #MethodValidation #SerialDilution #LabTechniques #RegulatoryAffairs #DrugDevelopment #LinkedInLearning #Labtip #analytical #HPLC #RP_HPLC #FTIR #Pharmaceutical_sciences #drugs

High-Performance Liquid Chromatography (HPLC) is one of the most critical analytical techniques in the pharmaceutical industry. To ensure accuracy, reliability, and compliance with regulatory requirements, HPLC calibration should be performed at regular intervals, typically every six months.
Essential calibration parameters and acceptance criteria:
Flow rate accuracy: Within ±0.5% of the set flow rate
Injector precision: %RSD of retention time and peak area ≤ 1.0%
Injector linearity: Correlation coefficient ≥ 0.99
Detector wavelength accuracy: Absorption maxima/minima must fall within specified wavelength tolerances
Detector linearity: Correlation coefficient ≥ 0.99
Gradient composition accuracy: %RSD ≤ 3.0%
Carry-over: ≤ 0.1% (may differ depending on company procedures)
Column oven temperature accuracy: Within ±2 °C of the set value
Baseline drift and noise: Drift ≤ 0.01 AU/hr; Noise ≤ 0.000125 AU
Why it matters:
Regular calibration ensures data integrity, reproducibility, and compliance with GMP requirements. It strengthens confidence in analytical results, supports regulatory audits, and ensures that decisions based on HPLC data are scientifically sound.
Recommended frequency: Every 6 months, or as defined in internal quality systems.
Consistent calibration leads to consistent results and reliable decision-making in pharmaceutical development and quality control.

1. Principle
LC-MS (Liquid Chromatography–Mass Spectrometry):
Separates analytes in the liquid phase using HPLC and detects them with a mass spectrometer.
Suitable for non-volatile, thermally labile, polar, and high-molecular-weight compounds.
GC-MS (Gas Chromatography–Mass Spectrometry):
Separates analytes in the gaseous phase using gas chromatography, followed by mass spectrometric detection.
Best suited for volatile, thermally stable, and low-molecular-weight compounds.
2. Sample Requirements
LC-MS: No need for volatility; minimal derivatization required.
GC-MS: Requires analytes to be volatile, or chemically derivatized to achieve volatility.
3. Ionization Techniques
LC-MS: Soft ionization methods such as ESI (Electrospray Ionization) and APCI (Atmospheric Pressure Chemical Ionization); ideal for large biomolecules.
GC-MS: Hard ionization methods like EI (Electron Ionization) or CI (Chemical Ionization); produce extensive fragmentation, aiding structural elucidation.
4. Destructive Nature
Both LC-MS and GC-MS are destructive techniques since analytes are ionized and fragmented. The difference lies in the type of data generated, sensitivity, and applicability.
Applications in Pharmaceuticals
LC-MS:
Impurity profiling (including genotoxic impurities – GTIs)
Bioanalytical studies (PK/PD, metabolism)
Peptide/protein characterization
Residual solvents & polar, non-volatile impurities
Stability studies of non-volatile degradants
GC-MS:
Residual solvent analysis (ICH Q3C compliance)
Detection of volatile organic impurities
Extractables & leachables assessment
Identification of volatile degradation products
Profiling of volatile intermediates
Regulatory Perspective
Regulatory agencies (FDA, EMA, ICH):
Recommend LC-MS/MS for genotoxic impurities, nitrosamines, and metabolites.
Recognize GC-MS as the standard for residual solvents (ICH Q3C).
In practice: Residual Solvents → GC-MS | Genotoxic Impurities → LC-MS
Summary
LC-MS and GC-MS are complementary, not interchangeable. The choice depends on analyte properties, sensitivity requirements, and regulatory guidance. The pharmaceutical industry applies both techniques in parallel rather than relying on just one.

One of the most important choices in chromatography method development is deciding between Normal-Phase (NP) and Reversed-Phase (RP) HPLC. The following comparison outlines the main differences:

Normal-Phase HPLC

The stationary phase is more polar than the mobile phase.

Common column types include Silica, Amino (NH2), Diol, and Cyano (CN).

The mobile phase usually consists of non-polar solvents such as hexane or ethyl acetate.

Polar compounds are retained for a longer time.

Reversed-Phase HPLC

The stationary phase is less polar than the mobile phase.

Typical columns include ODS (C18), C8, C4, Phenyl, and Cyano (CN).

The mobile phase often contains polar solvents such as water or acetonitrile.

Non-polar compounds are retained for a longer time.

The retention order of analytes is essentially reversed when switching between NP and RP systems—this principle lies at the core of chromatographic separation.

Choosing the appropriate phase depends on factors such as analyte polarity, sample solubility, and the desired separation outcome.

#HPLC #Chromatography #AnalyticalChemistry #Pharmaceuticals #PharmaIndustry #DrugDevelopment #SeparationScience #ResearchAndDevelopment #LabWork #QualityControl #QC #MethodDevelopment #AnalyticalMethods #Biopharma #ChemicalAnalysis #PharmaResearch #ChromatographicSeparation

In analytical science, precision is non-negotiable. Yet, one silent contaminant can distort results and jeopardize data integrity — carryover.

What is Carryover?
Carryover is the unintentional transfer of analyte from one sample injection to the next. Even trace residues can cause:

False positives

Inflated concentrations

Poor reproducibility

Regulatory non-compliance

Where Does It Come From?

Autosampler needle – inadequate washing

Syringe/injection port – especially in GC

Tubing and valves – adsorptive surfaces

Column or detector flow cell – strong retention

MS ion source – memory effects in LC-MS/MS

How to Detect It

Inject blanks after high-concentration samples

Watch for baseline drift or ghost peaks

Apply bracketing standards during validation

How to Prevent It

Use strong wash solvents with multiple rinses

Run a blank between critical samples

Select low-adsorption components (e.g., PTFE tubing)

Optimize autosampler wash/dwell times

Use column backflush or switching valves in GC

Apply divert valves or clean the source in LC-MS

Regulatory Perspective
Carryover evaluation is a required step in method validation as per ICH Q2(R1) and FDA/EMA guidelines.

Key Takeaway
Carryover may be subtle, but its consequences are serious. Prevent it with proper cleaning, smart method design, and strict validation practices.

#HPLC #GC #LCMS #AnalyticalChemistry #Carryover #MethodValidation #QAQC #Pharma #Biotech #Chromatography #RegulatoryCompliance #HPLCtraining #SkillDevelopment

During HPLC method validation for related substances, spiking impurities at levels below the LOQ may seem unnecessary—since values below LOQ are “not quantifiable.” However, this practice is critical for proving the sensitivity, robustness, and reliability of the method.
Purpose of Spiking Below LOQ
Detection Capability (LOD Check): Confirms impurities can still be distinguished from baseline noise at trace levels.
Specificity Verification: Ensures no interference from the API or excipients.
Regulatory Compliance: Meets ICH Q2(R1) requirements for sensitivity and selectivity.
Consistency Near Threshold: Assesses precision (%RSD) around detection limits, confirming method reliability.
Example
LOQ = 0.05%
Spike at 0.03% (below LOQ) → A reproducible peak should appear, demonstrating real detection capability.
Accuracy Studies – Spiking Levels
If the specification limit = 0.1%:
50% level → 0.05%
100% level → 0.10%
150% level → 0.15%
Adding a spike below LOQ (e.g., 0.03%) reinforces evidence of sensitivity.
Spiking Matrices
Placebo: Essential for assessing matrix interference.
API Solution: Supports selectivity data.
Finished Product: Best representation of real conditions.
Precision at Trace Levels
Although values below LOQ aren’t quantifiable, replicate injections (e.g., n=6) with and without spiking enable %RSD evaluation, confirming absence of random noise at trace levels.
⸻
Conclusion
Spiking below LOQ is not about quantifying impurities—it’s about demonstrating the method’s ability to consistently detect, discriminate, and remain stable at the lowest relevant levels. This builds scientific confidence and strengthens data integrity beyond regulatory compliance.
#PharmaceuticalAnalysis #HPLC #MethodValidation #ICHGuidelines #QualityAssurance #DrugImpurities

When using Acetonitrile and water composition in the ratio 50:50 premixed and sonicated for 10mins and ran one injection of blank,it's look like noisy baseline.so using nylon filter and used still te noise occurs.
I used this mobile phase in RS test with the run time of 70mins .

Give me a suggestion to reduce the noise by using this mobile phase.